AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CAMANCHACA.SN

Pes Camanchaca (CAMANCHACA.SN) fair value

Consumer Defensive · Farm Products · BCS · Chile
CLP 89.00+2.99%
Market cap CLP 358.7BUpdated Oct 24, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: there are no financial statements on file yet.
ACCE opinionPes Camanchaca (CAMANCHACA.SN)
Fair value
Not available
ACCE price target
CLP 97.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 20 Oct 2026, 02:20 CEST.
Price used: CLP 89.00 at the close on 23 Oct 2026, 21:00 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
74
out of 100
P/E
7.6x
forward 0.0x
1-year return
+47.6%
Dividend yield
0.00%

Pes Camanchaca in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Camanchaca is a Chilean salmon and seafood producer, selling farmed Atlantic salmon fillets and trout alongside wild-caught jack mackerel and hake, much of it into export markets such as the US and Japan. The moat is in the cost base: operating at a 17.6% margin, the company keeps more of each sale than most of its farmed-fish peers can, and the diversification into wild fisheries cushions it when salmon prices or disease events hit. Revenue grew 9.4% and return on equity sits at 12.1%, which is steady rather than spectacular for a business whose earnings swing with feed costs and harvest volumes. The stock trades at a trailing P/E of 7.4 with no forward estimate available, so the question for a PM is whether that multiple reflects cyclical peak earnings or a genuine discount. Worth a deeper look if you want exposure to Chilean protein with a pricing and margin profile that holds up better than the sector average, though the lack of index membership means liquidity and visibility will need checking before sizing.

AI-assisted·How I use AIWritten Oct 20, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CAMANCHACA.SN's valuation models land
Price
CLP 89.00
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+6.0%
1 month
+11.3%
3 months
+16.4%
6 months
+2.1%
YTD
+14.1%
1 year
+47.6%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
20 Oct 2026, 02:20 CESTACCE price targetCLP 97.00first publicationCLP 83.95

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in CLP. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CAMANCHACA.SN page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value87Quality61Momentum70Total74
Valuation
Trailing P/E
7.6x
Forward P/E
0.0x
PEG
0.21
P/B
0.87x
EV / Revenue
0.6x
Book value/sh
$0.10
Enterprise value
CLP 485.2B
Profitability
ROE
12.1%
FCF yield
10.15%
ROIC
6.2%
Health and risk
Debt / equity
0.48
Dividend yield
0.00%
Beta
0.35

Price

+43.5% · 1Y

Ask anything about CAMANCHACA.SN

Answered from Pes Camanchaca fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 60% of peers
low 0.0x7.6xhigh 176.6x
ROEbetter than 100% of peers
low -202%12%high 12%
Div yieldbetter than 50% of peers
low 0.0%0.0%high 3.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CAMANCHACA.SN Pes CamanchacaCLP 89.00--7.6x12.1%6174
LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)$3.60$1170% above--4.3%2723
VFF Village Farms International Inc. Common Shares$2.71$434% below15.1x7.5%7157
VITL Vital Farms Inc. Common Stock$9.41---0.1%4231
AFRI Forafric Global PLC Ordinary Shares$12.07----202.2%1331
2003.T Nitto Fuji Flour Milling Co.,Ltd.¥1957.00--21.7x6.7%5244
ALCO Alico Inc. Common Stock$37.08$1994% above176.6x0.7%4545

Sector report card

Where CAMANCHACA.SN ranks against its sector peers on each metric.

Computing percentiles…